News

Techniques Compared for Breast Tumor Detection


 

FROM SYMPOSIUM SPONSORED BY SOCIETY OF SURGICAL ONCOLOGY

The Canadian Breast Cancer Foundation funded the study. Dr. Lovrics and his coauthors reported no conflicts of interest.

Pages

Recommended Reading

Trastuzumab Benefit Persists at 4 Years in HER2-Positive Breast Cancer
MDedge Hematology and Oncology
FDA Grants Hearing on Withdrawal of Bevacizumab Approval
MDedge Hematology and Oncology
Eribulin Extends Survival of Women With Heavily Pretreated Breast Cancer
MDedge Hematology and Oncology
Plastic Surgery Groups Remove Cancer-Implant Webinar After Complaints
MDedge Hematology and Oncology
Optimal Therapy Elusive for Many Ovarian Cancer Patients With Medicare
MDedge Hematology and Oncology